As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as a ...

The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

SAN FRANCISCO, CA, UNITED STATES, January 13, 2026 /EINPresswire.com/ -- Bringing together public institutions, ...

UK biotech showed resilience in a tough 2025 for healthcare funding, suggesting investor interest could grow in 2026.

Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

Kos Biotechnology Partners ("Kos"), a global life sciences investment firm, today announced the closing of a financing round in Epikast, a premier provider of technology-enabled commercial and ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

European investment firm Gimv will no longer put funds into the life sciences sector, choosing instead to focus on its ...

In this podcast series, Alex Shandrovsky interviews investors about benchmarks for funding Alt Proteins in 2026 and uncovers the investment playbooks of ...

F. Hoffmann-La Roche, one of the world’s largest biotechnology companies, announced last week that it would more than triple ...

First announced in September 2025, the online platform is set to offer access to prescription medications at steep discounts, ...